126 related articles for article (PubMed ID: 2158205)
1. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
3. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
[TBL] [Abstract][Full Text] [Related]
5. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
Hirschman GH; DeLuca HF; Chan JC
Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
7. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
[TBL] [Abstract][Full Text] [Related]
8. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
[TBL] [Abstract][Full Text] [Related]
9. [Vitamin D-resistant rickets type II: apropos of 2 cases].
Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3.
Beamer WG; Wilson MC; DeLuca HF
Endocrinology; 1980 Jun; 106(6):1949-55. PubMed ID: 6892799
[TBL] [Abstract][Full Text] [Related]
11. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.
Balsan S; Garabedian M; Courtecuisse V; Guéris J; Dommergues JP; Creignou L; le Denuff MJ; Rivron J
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():225s-230s. PubMed ID: 203417
[TBL] [Abstract][Full Text] [Related]
12. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
Gertner JM; Brenton DB; Edwards RH
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
[TBL] [Abstract][Full Text] [Related]
13. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
[TBL] [Abstract][Full Text] [Related]
14. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
Aarskog D; Aksnes L; Markestad T
Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
[No Abstract] [Full Text] [Related]
16. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
[TBL] [Abstract][Full Text] [Related]
17. A single case of hypophosphatemic rickets with hypercalciuria.
Nishiyama S; Inoue F; Matsuda I
J Pediatr Gastroenterol Nutr; 1986; 5(5):826-9. PubMed ID: 3761117
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy of viramin D-resistant richets with 25-hydroxycholecalciferol.
Puschett JB; Genel M; Rastegar A; Anast C; DeLuca HF; Friedman A
Clin Pharmacol Ther; 1975 Feb; 17(2):202-11. PubMed ID: 164313
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphatemic vitamin D resistant rickets treatment with one alpha hydroxy vitamin D3.
Tragler A; Pai BU
Indian Pediatr; 1989 Apr; 26(4):386-8. PubMed ID: 2557284
[No Abstract] [Full Text] [Related]
20. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D.
Tsuchiya Y; Matsuo N; Cho H; Kumagai M; Yasaka A; Suda T; Orimo H; Shiraki M
J Clin Endocrinol Metab; 1980 Oct; 51(4):685-90. PubMed ID: 6252222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
